Insider · CIK 0002001438
Wan-Shan Chen
Files at BLTE (BELITE BIO, INC). First filing Apr 13, 2026, latest Apr 13, 2026.
In brief
Wan-Shan Chen files SEC Form 4 as director at BLTE (BELITE BIO, INC). Since Apr 13, 2026, Wan-Shan Chen has reported 0 open-market buys worth $0 and 1 open-market sell worth $198k, the latest filed on Apr 13, 2026.
A track record needs three past buys with six months of prices behind them; Wan-Shan Chen has 0, so none is measured yet.
The newest scored trade: sold $198k of BLTE on Apr 9, 2026, filed Apr 13, 2026, scored 27 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $198k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BLTE: BELITE BIO, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | BELITE BIO, INC | $198k 1,100 shares | -11% | +231% from low-5% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 9, 2026 | BLTE Belite Bio, Inc | 10,196 0.03% of outstanding | $2.2M | Apr 9, 2026 | none |
| Oct 17, 2025 | BLTE Belite Bio, Inc | 9,550 0.03% of outstanding | $1.2M | Oct 17, 2025 | $173k |
| Oct 16, 2025 | BLTE Belite Bio, Inc | 1,050 0.00% of outstanding | $89k | Oct 16, 2025 | $84k |
| Oct 14, 2025 | BLTE Belite Bio, Inc | 1,050 0.00% of outstanding | $84k | Oct 13, 2025 | none |
| Nov 28, 2023 | BLTE Belite Bio Inc | 6,000 0.02% of outstanding | $225k | Nov 28, 2023 | none |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | BLTE BELITE BIO, INC | SOpen-market sale American depositary share10b5-1 | -1,100 | $180.43 | $198k | 9,096 | Apr 13, 2026 |
| Mar 31, 2026 | BLTE BELITE BIO, INC | AGrant or award Stock Option (right to buy)derivative | +13,796 | $0.00 | $0 | 13,796 | Apr 2, 2026 |
Questions about Wan-Shan Chen
Answered from the filings on this page, as of the latest one.
Is Wan-Shan Chen buying or selling?
In the last 12 months Wan-Shan Chen reported 0 open-market buys worth $0 and 1 open-market sell worth $198k on SEC Form 4; the latest was sold $198k of BLTE on Apr 9, 2026. Grants, option exercises and tax withholding are not counted.
How did Wan-Shan Chen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Wan-Shan Chen has 0.
Where does Wan-Shan Chen file Form 4?
Wan-Shan Chen has filed Form 4 at BLTE (BELITE BIO, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.